NSEGeneral Updates5d ago · 15 Oct 2026, 08:40 pm

General Updates

Mankind Pharma Limited · MANKIND

✦ AI SummaryESG

Mankind Pharma Limited has received an ESG rating of '71' from NSE Sustainability, a SEBI registered ESG Rating Provider, for FY26, based on publicly available information.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mankind Pharma Limited has informed the Exchange about General Updates

Attachments (1)

📄

MANKIND1_15102026204014_ESGRatingIntimation.pdf

pdf

Download →
View document text
October 15, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Intimation of Environmental, Social and Governance (ESG) Rating Ref.: Regulation 30 & 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to Regulations 30 and 51 of the Listing Regulations, we wish to inform you that NSE Sustainability Ratings and Analytics Limited (“NSE Sustainability”), a SEBI registered ESG Rating Provider, has assigned the Environmental, Social, and Governance (ESG) Rating of ‘71’ to the Company. The Company has not engaged NSE Sustainability for the said rating, same has been independently assigned by NSE Sustainability for FY26, based on publicly available information. The above disclosure is also being made available on the Company’s website at www.mankindpharma.com. This is for your information and records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer